Application 078462
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 25MG | No | No |
| 002 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 50MG | No | No |
| 003 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 100MG | No | No |
| 004 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078462-001 | TOPIRAMATE | TOPIRAMATE | 25MG | TABLET / ORAL | AB | 2009-03-27 | |
| A078462-002 | TOPIRAMATE | TOPIRAMATE | 50MG | TABLET / ORAL | AB | 2009-03-27 | |
| A078462-003 | TOPIRAMATE | TOPIRAMATE | 100MG | TABLET / ORAL | AB | 2009-03-27 | |
| A078462-004 | TOPIRAMATE | TOPIRAMATE | 200MG | TABLET / ORAL | AB | 2009-03-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078462-001 | AB |
| A078462-002 | AB |
| A078462-003 | AB |
| A078462-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078462-001 | TOPIRAMATE | 25MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078462-002 | TOPIRAMATE | 50MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078462-003 | TOPIRAMATE | 100MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078462-004 | TOPIRAMATE | 200MG | TABLET / ORAL | AB | 2009-03-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078462-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078462-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078462-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078462-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 4833f2e8-16b7-406f-937a-55bc978bf92c | 2026-07-29 | Warnings, Adverse reactions | 078462 ANDA078462 |
| Topiramate | TOPIRAMATE | Aurobindo Pharma Limited | 32b48ea0-a215-43b8-83b4-a5435a686d68 | 2026-03-24 | Warnings, Adverse reactions | 078462 ANDA078462 65862-172 65862-174 65862-173 65862-171 |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 5424d59e-74f1-4c3c-b737-79e9776e0b60 | 2026-03-23 | Warnings, Adverse reactions | 078462 ANDA078462 |
| Topiramate | TOPIRAMATE | NCS HealthCare of KY, LLC dba Vangard Labs | 444464fb-6a95-4e10-99a7-fdbc7dbb4c48 | 2025-10-31 | Warnings, Adverse reactions | 078462 ANDA078462 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 16571-705 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-705 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-705 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-705 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-706 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-706 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-706 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-706 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-707 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-707 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-707 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-707 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-708 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-708 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-708 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 16571-708 | Topiramate | Topiramate | Rising Pharma Holdings, Inc. | ANDA | Current |
| 57237-134 | Topiramate | Topiramate | Citron Pharma LLC | ANDA | Current |
| 57237-135 | Topiramate | Topiramate | Citron Pharma LLC | ANDA | Current |
| 57237-136 | Topiramate | Topiramate | Citron Pharma LLC | ANDA | Current |
| 57237-137 | Topiramate | Topiramate | Citron Pharma LLC | ANDA | Current |
| 65862-171 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-171 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-171 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-171 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-171 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-171 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-171 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-172 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-172 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-172 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-172 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-172 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-172 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-172 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-173 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-173 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-173 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-173 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-173 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-173 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-173 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-174 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-174 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-174 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-174 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-174 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-174 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 65862-174 | Topiramate | Topiramate | Aurobindo Pharma Limited | ANDA | Current |
| 70518-3460 | Topiramate | Topiramate | REMEDYREPACK INC. | ANDA | Current |
| 80425-0202 | Topiramate | Topiramate | Advanced Rx Pharmacy of Tennessee, LLC | ANDA | Current |